NeuroQuest
Immuno-based Blood Tests for Early Detection of Alzheimer's Disease
Active
A
Startup
Founded 2008-01
NeuroQuest has developed NeuroScreen™, a novel blood-based diagnostic test for Alzheimer's disease (AD). The technology is based on the specific response of the immune system to a amyloid-beta accumulation. The company's propriety technology is based on the award-winning research of Professor Michal Schwartz of the Weizmann Institute of Science. NeuroQuest…
SectorHealth Tech & Life Sciences
StageA
Total raised$1.8M
Employees7
Founded2008-01
Crunchbaseneuroquest
Patents1
Confidence90
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersLaboratories